NCT03170778

Brief Summary

The purposes of this study are to identify indicators of vision problems and ocular abnormalities in patients with a Fontan circulation through a standardized questionnaire and to correlate the intraocular pressure measured with the Icare tonometer with central venous pressure measured with the VENUS 2000 CVP non-invasive system to determine whether intraocular pressure can be used as a surrogate measure of increased central venous pressure in patients with a Fontan circulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2016

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 31, 2017

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

May 4, 2022

Status Verified

May 1, 2022

Enrollment Period

6.2 years

First QC Date

April 26, 2017

Last Update Submit

May 3, 2022

Conditions

Keywords

Congenital Heart DiseaseCHDFontan

Outcome Measures

Primary Outcomes (1)

  • Reported ocular medical history in Fontans

    Number of participants with Fontan physiology that have undergone a Fontan operation that have reported any changes in ocular and vision abnormalities by using a standardized survey.

    The final 3 months will be used for data analysis and the presentation/manuscript preparation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will be conducted solely in the the Adult Congenital Heart Clinic at Stanford, and patients with congenital heart disease (CHD) will be recruited for the study.

You may qualify if:

  • Patients (male and female) 18 and older with Fontan circulation

You may not qualify if:

  • Patients under 18.
  • Patients with any prior ocular trauma or surgery.
  • Patients unwilling to consent to study.
  • Patients who are unable to speak and read English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Hospital Adult Congenital Heart Clinic

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Susan Fernandes, LPD, PA-C

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, Pediatrics - Cardiology Clinical Professor, Medicine - Cardiovascular Medicine

Study Record Dates

First Submitted

April 26, 2017

First Posted

May 31, 2017

Study Start

February 13, 2016

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

May 4, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations